Patents by Inventor John M. Berge

John M. Berge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for making extruded granular absorbent and clumping granular absorbent
    Patent number: 11950565
    Abstract: A method of making an extruded granular absorbent is provided where the method includes providing an extruder and a starch-containing admixture, and pressurizing the starch containing admixture in the extruder under relatively high extrusion pressures to extrude the pressurized starch-containing admixture from the extruder, and producing a water absorbent and oil absorbent extrudate. The present invention further provides that the extruded granular absorbent may be combined with a non-extruded granular material with relatively high inert or cellulose content where there may be a greater proportion of extruded granular absorbent, and the extruded granular absorbent and non-extruded granular material agglutinate into a clump when wetted with water or urine.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: April 9, 2024
    Assignee: Pioneer Pet Products, LLC
    Inventors: John M. Lipscomb, Omar I. Rodriguez, Chad C. Berge
  • Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity
    Patent number: 5519006
    Type: Grant
    Filed: March 30, 1995
    Date of Patent: May 21, 1996
    Assignee: SmithKline Beecham plc
    Inventors: Lee J. Beeley, John M. Berge, Richard L. Jarvest
  • Heterocyclic compounds useful as .alpha..sub.2 -adrenoceptor antagonists
    Patent number: 5310750
    Abstract: A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt thereof, wherein: R.sup.1 and R.sup.2 may each represent hydrogen or alkyl providing that at least one of R.sup.1 or R.sup.2 represents alkyl;R.sup.3 and R.sup.4 each represent hydrogen or R.sup.3 and R.sup.4 together represent a bond;n represents an integer 1 or 2;and m represents an integer 1 or 2; a composition containing such a compound and the method of using such compounds and compositions in medicine.
    Type: Grant
    Filed: March 1, 1991
    Date of Patent: May 10, 1994
    Assignee: Beecham Group P.L.C.
    Inventors: John M. Berge, Michael A. Cawthorne
  • Heterocyclic compounds which have useful pharmaceutical utility
    Patent number: 5264436
    Abstract: A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt, ester or amide thereof, or a pharmaceutically acceptable solvate thereof, wherein:Z represents a residue of a substituted or unsubstituted aryl group,A.sub.1 represents a substituted or unsubstituted methylene group or a substituted or unsubstituted ethylene group;A.sub.2 represents a substituted or unsubstituted methylene group or a substituted or unsubstituted ethylene group;providing that at least one of A.sup.1 or A.sup.2 represents a substituted methylene group or a substituted ethylene group,X represents O or NR.sup.o wherein R.sup.
    Type: Grant
    Filed: September 16, 1991
    Date of Patent: November 23, 1993
    Assignee: Beecham Group p.l.c.
    Inventors: John M. Berge, Lee J. Beeley
  • Imidazole substituted compounds which have useful pharmaceutical utility
    Patent number: 5077299
    Abstract: A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt, ester or amide thereof, or a pharmaceutically acceptable solvate thereof, wherein:Z represents a residue of a substituted or unsubstituted aryl group,A.sup.1 represents a substituted or unsubstituted methylene group or a substituted or unsubstituted ethylene group;A.sup.2 represents a substituted or unsubstituted methylene group or a substituted or unsubstituted ethylene group;providing that at least one of A.sup.1 or A.sup.2 represents a substituted methylene group or a substituted ethylene group,X represents O or NR.sup.0 wherein R.sup.
    Type: Grant
    Filed: March 14, 1990
    Date of Patent: December 31, 1991
    Assignee: Beecham Group p.l.c.
    Inventors: John M. Berge, Lee J. Beeley
  • Compounds useful for the treatment of hypoglycemia
    Patent number: 5021445
    Abstract: A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt thereof, wherein: R.sup.1 and R.sup.2 may each represent hydrogen or alkyl providing that at least one of R.sup.1 or R.sup.2 represents alkyl;R.sup.3 and R.sup.4 each represent hydrogen or R.sup.3 and R.sup.4 together represent a bond;n represents an integer 1 or 2;and m represents an integer 1 or 2; a composition containing such a compound and the use of such compounds and compositions in medicine.
    Type: Grant
    Filed: September 10, 1990
    Date of Patent: June 4, 1991
    Assignee: Beecham Group P.L.C.
    Inventors: John M. Berge, Michael A. Cawthorne
  • Novel compounds
    Patent number: 4959374
    Abstract: A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt, ester or amide thereif, wherein: Z represents a residue of a substituted or unsubstituted aryl group,X represents o or NR.sup.o wherein R.sup.0 represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, an alkanoyl group substituted or unsubstituted in the alkyl moiety, or an arylalkyl moiety substituted or unsubstituted in the aryl moiety,n represents an integer 1 or 2,m represents an integer 1 or 2,p represents an integer 2 or 3,andq represents an integer in the range of from 1 to 12; pharmaceutical compositions containing such compounds and the use of such compounds and compositions in medicine.
    Type: Grant
    Filed: July 6, 1989
    Date of Patent: September 25, 1990
    Assignee: Beecham Group P.L.C.
    Inventor: John M. Berge
  • 4,5 Dihydroimidazole compounds which have useful pharmaceutical utility
    Patent number: 4918083
    Abstract: A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt, ester or amide thereof, or a pharmaceutically acceptable solvate thereof, wherein:Z represents a residue of a substituted or unsubstituted aryl group,A.sup.1 represents a substituted or unsubstituted methylene group or a substituted or unsubstituted ethylene group;A.sup.2 represents a substituted or unsubstituted methylene group or a substituted or unsubstituted ethylene group;providing that at least one of A.sup.1 or A.sup.2 represents a substituted methylene group or a substituted ethylene group,X represents O or NR.sup.o wherein R.sup.
    Type: Grant
    Filed: November 24, 1987
    Date of Patent: April 17, 1990
    Assignee: Beecham Group p.l.c.
    Inventors: John M. Berge, Lee J. Beeley
  • 2-[2H-(1,3-dihydroisoindole)alkylene]-4,5-dihydroimidazoles and pharmaceutical compositions thereof
    Patent number: 4863946
    Abstract: A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt, ester or amide thereof, wherein: Z represents a residue of a substituted or unsubstituted aryl group,X represents O or NR.sup.o wherein R.sup.o represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, an alkanoyl group substituted or unsubstituted in the alkyl moiety, or an arylalkyl moiety substituted or unsubstituted in the aryl moiety.n represents an integer 1 or 2,m represents an integer 1 or 2,p represents an integer 2 or 3, andq represents an integer in the range of from 1 to 12; pharmaceutical compositions containing such compounds and the use of such compounds and compositions in medicine.
    Type: Grant
    Filed: December 1, 1986
    Date of Patent: September 5, 1989
    Assignee: Beecham Group plc
    Inventor: John M. Berge